These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 3279629)
1. Two immunosuppressive drug regimens after renal transplantation: low dosage of cyclosporine adjusted on the basis of high-performance liquid chromatography whole blood levels and prednisone. Uchida K; Orihara A; Yamada N; Tominaga Y; Kawai M; Tanaka Y; Morozumi K; Hayashi S; Satake M; Taira N Transplant Proc; 1988 Feb; 20(1 Suppl 1):401-5. PubMed ID: 3279629 [No Abstract] [Full Text] [Related]
2. Minimal low dosage of cyclosporine therapy in renal transplantation by careful monitoring of high-performance liquid chromatography whole blood trough levels. Uchida K; Yamada N; Orihara A; Tominaga Y; Tanaka Y; Hayashi S; Kondo T; Morozumi K; Satake M; Taira N Transplant Proc; 1988 Apr; 20(2 Suppl 2):394-401. PubMed ID: 3284083 [No Abstract] [Full Text] [Related]
3. Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy. Stiller C; Keown P Transplant Proc; 1990 Jun; 22(3):1253-4. PubMed ID: 2349687 [No Abstract] [Full Text] [Related]
4. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone. Simmons RL; Canafax DM; Strand M; Ascher NL; Payne WD; Sutherland DE; Najarian JS Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665 [No Abstract] [Full Text] [Related]
5. A single center experience with "low-dose" cyclosporine in cadaveric renal transplantation. Fries D; Hiesse C; Charpentier B; Lantz O; Bensadoun H; Benoit G Clin Transpl; 1988; ():115-29. PubMed ID: 3154465 [No Abstract] [Full Text] [Related]
6. Adjustment of cyclosporine dosage in renal transplant patients based on concentration measured specifically in whole blood: clinical outcome results and diagnostic utility. Shaw LM; Audet PR; Grossman RA; Fields L; Lensmeyer GL; Dafoe DC Transplant Proc; 1990 Jun; 22(3):1267-73. PubMed ID: 2349688 [No Abstract] [Full Text] [Related]
7. Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in blood. Moyer TP; Post GR; Sterioff S; Anderson CF Mayo Clin Proc; 1988 Mar; 63(3):241-7. PubMed ID: 3278174 [TBL] [Abstract][Full Text] [Related]
8. Comparison of five cyclosporine-prednisone regimens for induction of immunosuppression in cadaveric kidney recipients: a retrospective analysis of 245 cases. Kahan BD; Lorber MI; Flechner SM; Van Buren CT; Jensen C; Wideman CA Transplant Proc; 1986 Apr; 18(2 Suppl 1):59-65. PubMed ID: 3515696 [No Abstract] [Full Text] [Related]
9. Sequential conventional immunotherapy with maintenance cyclosporine following renal transplantation. Sommer BG; Henry ML; Ferguson RM Transplant Proc; 1986 Apr; 18(2 Suppl 1):69-75. PubMed ID: 3515698 [No Abstract] [Full Text] [Related]
10. [Spontaneous kidney transplant rupture--effect of immunosuppressive therapy on incidence of rupture]. Oesterwitz H; Strobelt V; May G; Horlbeck R Z Urol Nephrol; 1990 Apr; 83(4):157-63. PubMed ID: 2378176 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of a low-dose two-drug regimen of oral cyclosporine and delayed alternate day prednisone for immunosuppression in cadaver kidney transplantation. Belitsky P; MacDonald A; Cohen A; VGivner M; Sketris I Transplant Proc; 1988 Jun; 20(3 Suppl 3):78-81. PubMed ID: 3291314 [No Abstract] [Full Text] [Related]
12. [Renal function in the immediate postoperative period after heart transplantation using very low initial doses of cyclosporin A]. Cladellas M; Sánchez JM; Abadal ML; Ballester M; Obrador D; Amengual MJ; Quintana E; Net A; Cámara ML; Padró JM Rev Esp Cardiol; 1987; 40 Suppl 2():70-3. PubMed ID: 3331810 [No Abstract] [Full Text] [Related]
13. Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection, or good renal function: comparative high-performance liquid chromatography and monoclonal radioimmunoassay studies. Rosano TG; Pell MA; Freed BM; Dybas MT; Lempert N Transplant Proc; 1988 Apr; 20(2 Suppl 2):330-8. PubMed ID: 3284076 [No Abstract] [Full Text] [Related]
14. The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation. First MR; Alexander JW; Wadhwa N; Penn I; Munda R; Fidler JP; Weiskittel P Transplant Proc; 1986 Apr; 18(2 Suppl 1):132-5. PubMed ID: 3515680 [No Abstract] [Full Text] [Related]
15. A randomized study comparing high- and low-dose regimens of cyclosporine in renal transplantation. Kootte AM; Lensen LM; van Bockel JH; Paul LC Transplant Proc; 1988 Jun; 20(3 Suppl 3):136-9. PubMed ID: 3291227 [No Abstract] [Full Text] [Related]
16. Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients. Awni WM; Heim-Duthoy K; Kasiske BL Transplant Proc; 1990 Jun; 22(3):1343-4. PubMed ID: 2349693 [No Abstract] [Full Text] [Related]
17. First month cyclosporine A sparing in renal transplantation. Segoloni GP; Messina M; Colla L; Piccoli GB; Triolo G; Vercellone A Transplant Proc; 1988 Jun; 20(3 Suppl 3):233-8. PubMed ID: 3291249 [No Abstract] [Full Text] [Related]